111 Capital reduced its position in shares of Kimberly-Clark Co. (NYSE:KMB - Free Report) by 76.0% in the second quarter, according to its most recent filing with the SEC. The fund owned 1,914 shares of the company's stock after selling 6,067 shares during the quarter. 111 Capital's holdings in Kimberly-Clark were worth $247,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of KMB. Vanguard Group Inc. lifted its position in Kimberly-Clark by 0.3% during the first quarter. Vanguard Group Inc. now owns 35,235,465 shares of the company's stock valued at $5,011,188,000 after purchasing an additional 92,920 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in shares of Kimberly-Clark by 6.4% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 11,264,013 shares of the company's stock valued at $1,601,968,000 after acquiring an additional 674,046 shares during the last quarter. Price T Rowe Associates Inc. MD grew its position in Kimberly-Clark by 7.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 8,095,260 shares of the company's stock worth $1,151,309,000 after acquiring an additional 566,152 shares in the last quarter. Invesco Ltd. increased its stake in Kimberly-Clark by 3.1% during the first quarter. Invesco Ltd. now owns 5,827,666 shares of the company's stock worth $828,811,000 after acquiring an additional 173,915 shares during the last quarter. Finally, Royal Bank of Canada raised its position in Kimberly-Clark by 0.9% during the first quarter. Royal Bank of Canada now owns 3,460,069 shares of the company's stock valued at $492,091,000 after purchasing an additional 29,453 shares during the period. Institutional investors own 76.29% of the company's stock.
Kimberly-Clark Stock Down 1.7%
Shares of NYSE KMB opened at $120.54 on Tuesday. Kimberly-Clark Co. has a 52-week low of $120.45 and a 52-week high of $150.45. The firm has a market capitalization of $39.99 billion, a price-to-earnings ratio of 15.97, a PEG ratio of 4.46 and a beta of 0.30. The stock has a 50 day moving average price of $128.72 and a 200 day moving average price of $132.51. The company has a debt-to-equity ratio of 7.05, a quick ratio of 0.54 and a current ratio of 0.80.
Kimberly-Clark (NYSE:KMB - Get Free Report) last issued its earnings results on Friday, August 1st. The company reported $1.92 earnings per share for the quarter, beating analysts' consensus estimates of $1.67 by $0.25. Kimberly-Clark had a return on equity of 201.43% and a net margin of 12.69%.The business had revenue of $4.16 billion during the quarter, compared to analyst estimates of $4.85 billion. During the same period in the previous year, the company posted $1.96 EPS. Kimberly-Clark's revenue was down 1.6% on a year-over-year basis. Sell-side analysts expect that Kimberly-Clark Co. will post 7.5 earnings per share for the current year.
Kimberly-Clark Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, October 2nd. Investors of record on Friday, September 5th were paid a $1.26 dividend. The ex-dividend date of this dividend was Friday, September 5th. This represents a $5.04 dividend on an annualized basis and a yield of 4.2%. Kimberly-Clark's dividend payout ratio is 69.42%.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently commented on KMB shares. Wells Fargo & Company dropped their target price on Kimberly-Clark from $140.00 to $130.00 and set an "equal weight" rating for the company in a report on Thursday, September 25th. Barclays cut their price objective on shares of Kimberly-Clark from $139.00 to $131.00 and set an "equal weight" rating on the stock in a research report on Wednesday, October 1st. JPMorgan Chase & Co. upgraded shares of Kimberly-Clark from an "underweight" rating to a "neutral" rating and raised their target price for the stock from $125.00 to $138.00 in a report on Monday, August 4th. UBS Group cut their price target on shares of Kimberly-Clark from $146.00 to $139.00 and set a "neutral" rating on the stock in a report on Thursday, July 17th. Finally, Piper Sandler decreased their price objective on shares of Kimberly-Clark from $149.00 to $145.00 and set an "overweight" rating for the company in a research note on Thursday. Three research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $140.50.
Read Our Latest Analysis on KMB
Kimberly-Clark Profile
(
Free Report)
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kimberly-Clark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.
While Kimberly-Clark currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.